In addition, GATA3 expression was correlated with two clinical parameters, B symptom presentation (Pearson, p = 0.000; Table 4) and hemophagocytic syndrome incidence (Fisher, p = 0.041; Table 4). Here, GATA3 is linked to hemophagocytic syndrome.